You are receiving this email because of your relationship with Chi's Enterprise, Inc.. Please reconfirm your interest in receiving email from us. If you do not wish to receive any more emails, you can unsubscribe here
MYOMIN: Non-Invasive Alternative to Fibroid Surgery that can Spread Cancer
CHI HEALTH | June 6, 2014
FDA warns against invasive procedure used in fibroid surgery that can spread cancer

An advisory recently issued by the FDA warned doctors against a laparoscopic procedure called morcellation used in hysterectomies and fibroid surgeries that can unintentionally spread cancerous tissue. The FDA reports that women who undergo this procedure for what may look like benign fibroids have a 1 in 350 chance of spreading undetected uterine sarcoma. Once this cancerous tissue spreads, the cancer can be more difficult to treat.

As many of you probably know, any type of invasive procedure (e.g., laparoscopy, biopsy, etc.) carries the risk of spreading cancerous cells. This is a known fact in breast cancer, lung cancer, colon cancer, and other types of cancer. When it comes to uterine fibroids, there is no known medical method of determining in advance whether it is cancerous. What we do know is that estrogen contributes toward the growth of uterine fibroids.

This was seen in the case of a 24-year old female. When she was 21 years old, she had what they thought was a fibroid. After the da Vinci surgery was performed, they found it was actually low grade endometrial sarcoma of the uterus. A year later, she started having stomachaches. A CT scan revealed that she had tumors in the spleen and colon. Later the tumors were surgically removed and found to be estrogen positive.
This is an excellent example of how even with a minimally invasive procedure like the da Vinci surgery the risk of spreading the cancer is high. Indeed, in this case, the estrogen-positive cancerous cells spread from the uterus to the spleen and colon.
MYOMIN corrects Excess Estrogen for Uterine Fibroids and more

Correcting excess estrogen through natural means is a much better and safer alternative to surgery. Moreover, it does not carry the risk of spreading undetected cancer cells. Many studies and case reports have attested to the effectiveness of MYOMIN in managing estrogen levels as well as in reducing uterine fibroids.

It is a well-established fact that uterine fibroids, endometriosis and similar conditions respond to estrogen. What is interesting is that there is localized aromatase overexpression and, consequently, estrogen production in these tissues. So local levels of estrogen just keeps increasing and fueling the growth of these tissues. Taking Myomin, therefore, will effectively control the growth of uterine fibroids, endometriosis, etc, by reducing aromatase expression and estrogen production at the site.

Myomin reduces Fibroids in 60 patients
Myomin was used in a study on 60 patients with uterine fibroids. In combination with Angiostop, it was 69.2% effective in eliminating the fibroids (see figure). When uterine fibroids exceed 2.5 cm3 in size, the addition of Angiostop, a sea cucumber extract, is recommended for synergistic results.

The case reports to the right are some of the latest ones we received, showing how effective Myomin is on uterine fibroids.

Besides its effect on uterine fibroids and endometriosis, Myomin is also beneficial for other estrogen-responsive conditions in women like fibrocystic breasts, ovarian cysts, belly fat, and tumors in the reproductive organs.

Buy MYOMIN now!

Case Reports: Myomin Reduces Estrogen and Eliminates Fibroids

CASE 1
Y. Dikansky, ND, DDS from New York, has a 47 y/o/f patient, Daira P., with multiple fibroids. One of them was 4cm in diameter. After taking Myomin and Angiostop for 6 months, her doctor declares that her fibroids have cleared

CASE 2
Kristin D., 47 y/o/f from California, has had adenomyosis for years. Adenomyosis is thickening of the uterine wall due to ectopic growth of endometrial tissue. Because of this uterine thickening, she’s had chronic abrnomal menstrual bleeding and endometrial pain for 7 years. Then she started taking Angiostop, Myomin and Chi-F. After 2 months, her pain alleviated and her abnormal menstrual bleeding cleared. Now she continues to take Myomin and Chi-F. Phone number is (310) 207-0586.

CASE 3
V. Jefferson, DC from New York, has a 58 y/o/f patient on bio-identical estrogen and progesterone. She has a myoma the size of a 7-month fetus and heavy bleeding. She’s already had a 6-pint blood transfusion but was frustrated because she was still bleeding. She was so thrilled because only a day after she took Angiostop, Myomin and Revivin, her bleeding stopped. Since then, her symptoms improved. A year later, her myoma is much smaller, and she had no more bleeding.

Because of its many benefits, women in their 40s and beyond should take Myomin, especially those who are on some type of hormone replacement therapy (HRT or BHRT) or who have a history of birth control use. Diet, lifestyle and environmental hormones contribute towards estrogen dominance, so taking Myomin would help counteract the unwanted effects from this imbalance.

UPCOMING EVENTS
Please also visit our EVENTS page for updates.
DR. CHI'S WORKSHOP

August 16-17, 2014
Anaheim, CA

12 CEUs
Chiropractors
Acupuncturists
Naturopaths
in some states


Early Bird Discount ends June 13

Call (714) 777-1542 to Register Now

PATIENT SCREENING

June 9-13
Wycoff Wellness Center
Lansing, Michigan
(517) 333-7270
Free Lecture on June 10 at 6:30 pm

June 14
Rodnick Chiropractic
(989) 832-7535
Midland, Michigan
Commerce, Michigan

June 16
Arbor West Chiropractic
(734) 995-8770
Ann Arbor, Michigan
CONVENTIONS

August 31-September 1
Cancer Control Convention
Sheraton Universal
Los Angeles
Booth 13

September 5-7
American Naturopathic Medical Convention
Riviera Hotel
Las Vegas
Booth 204
Dr. Chi will be giving a lecture and workshop on September 5 and 6

October 3-5
Alaska Chiropractic Society Convention
Anchorage Hilton Hotel
Anchorage, Alaska
Dr. Chi will be giving two lectures for a total of 8 Clinical Credits!

Get more Myomin case reports and articles today. Email your request to postmaster@chi-health.com.
Or call (800) 457-5708

[BME_CANSPAM:This message was sent to test@benchmarkemail.com by Chi's Enterprise, Inc.]
[BME_ADDRESS:1435 N. Brasher Street Anaheim, CA 92807]


[BME_LINKS:Unsubscribe from all mailingsManage Subscription | Forward Email | Report Abuse]
[BME_BADGE:]